National Government Services Criteria: ,  Region:  |  Change Criteria
  Medicare Monthly Review 

Note: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material which is copyrighted by the American Medical Association (AMA). You are forbidden to download the files unless you read, agree to and abide by the provisions of the copyright statement. Read the copyright statement now (you will be linked back to here).

CMS Logo
National Government Services, Inc.

Medicare Monthly Review Part A and B
A Combined Part A and Part B Newsletter
July 2008

MLN Matters. . .Information for Medicare Providers
(Issued by the Centers for Medicare & Medicaid Services)

Part B Information

MLN Matters Matters Number: MM6021
Related Change Request (CR) #: 6021
Related CR Release Date: May 30, 2008
Effective Date: July 1, 2008
Related CR Transmittal #: R1527CP
Implementation Date: July 7, 2008


Clinical Laboratory Fee Schedule - New Waived Tests

 

 

Provider Types Affected
Clinical diagnostic laboratories that bill Medicare carriers or Part A/B Medicare Administrative Contractors (A/B MAC) for laboratory tests

What You Need to Know
CR 6021 announces the latest tests that the Food and Drug Administration (FDA) has approved (effective July 1, 2008) as waived tests under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

Please be aware that In order for a laboratory with a valid, current certificate of waiver to bill for these tests, the assigned Current Procedural Terminology (CPT) codes must contain the QW modifier. The new waived tests, CPT codes, and effective dates for each are provided in Table 1, below.

Make sure that your billing staffs are aware of these newly approved FDA waived tests under CLIA.

Background
Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations require that a laboratory facility be appropriately certified for each test that it performs. Further, these regulations require facilities with a Certificate of Waiver (COW) to perform only CLIA waived tests

Note: To ensure that Medicare only pays laboratories with a CLIA certificate of waiver for tests that are approved as waived complexity under the Clinical Laboratory Fee Schedule (CLFS), laboratory claims are currently edited at the CLIA certificate level.

In addition, the Centers for Medicare & Medicaid Service (CMS) is mandated by Section 1833(h) of the Social Security Act to add updated test codes to the CLFS, and CR 6021 announces the latest tests that the FDA has approved as waived tests under CLIA.

In order for a CLIA-enrolled, waived laboratory to bill for these tests, the Current Procedural Terminology (CPT) codes associated with them must contain a QW modifier. Table 1, below, lists the CPT codes, descriptions, and effective dates for these latest tests that the FDA has approved as waived tests under CLIA. Please note that the CPT codes for the tests in the table must have the modifier QW to be recognized as waived tests.


Table 1
FDA-Approved Waived Tests under CLIA

CPT Code
Description
80047QW dates of service on or after January 1, 2008 Basic Metabolic Panel (Calcium, Ionized)
80048QW dates of service on or after January 16, 2008 Basic Metabolic Panel, (Calcium, total)
80051QW dates of service on or after October 30, 2007 Electrolyte Panel
80053QW dates of service on or after January 16, 2008 Comprehensive Metabolic Panel
82042QW dates of service on or after October 4, 2006 Albumin; Urine or Other source, Quantitative, Each Specimen
82150QW dates of service on or October 4, 2006 Amylase
82247QW dates of service on or after October 4, 2006 Bilirubin; Total
82977QW dates of service on or after October 4, 2006 Glutamyltransferase, Gamma (GGT)
84075QW dates of service on or after October 4, 2006 Phosphatase, Alkaline
84157QW dates of service on or after October 4, 2006 Protein, Total, Except by Refractometry; Other Source (e.g., Synovial Fluid, Cerebrospinal Fluid)
84520QW dates of service on or after October 4, 2006 Urea Nitrogen; Quantitative
87808QW dates of service on or after January 1, 2007 Infectious Agent Antigen Detection by Immunoassay with Direct Optical Observation; Trichomonas Vaginalis
87999QW dates of service on or after July 1, 2007 Unlisted Microbiology Procedure


Be aware that carriers and A/B MACS will not search their files to either retract payment or retroactively pay claim processed prior to implementation of CR6021, but they will adjust such claims if you bring them to their attention.

Additional Information
You can find the official instruction to your carrier or A/B MAC by going to CR 6021, located at http://www.cms.hhs.gov/Transmittals/downloads/R1527CP.pdf on CMS Web site.

If you have any questions, please contact your carrier or A/B MAC at their toll-free number, which may be found at http://www.cms.hhs.gov/MLNProducts/downloads/CallCenterTollNumDirectory.zip on the CMS Web site.

Disclaimer This article was prepared as a service to the public and is not intended to grant rights or impose obligations. This article may contain references or links to statutes, regulations, or other policy materials. The information provided is only intended to be a general summary. It is not intended to take the place of either the written law or regulations. We encourage readers to review the specific statutes, regulations and other interpretive materials for a full and accurate statement of their contents.

  Untitled Page News and Publications Links
What’s New
E-Commerce Connection
Listserv Sign Up
Medicare Monthly Review
Adobe Acrobat Download
  Untitled Page




What's New
View News by Specialty or Interest
Or View All    




 
  Untitled Page
Untitled Page Centers for Medicare & Medicaid Services
 

©2007 National Government Services, Inc. All rights reserved.        Privacy Policy | Site Map | Site Feedback | About Us | Contact Us